What they were paid
Ovid Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $70,000 | $0 | $19,940 | $0 | $89,940 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ovid Therapeutics Inc. DEF 14A filed April 27, 2026, accession 0001628280-26-027621, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Ovid Therapeutics pays directors a $45,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair) · Nominating/Governance
The rest of the Ovid Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Barbara Duncan | Independent Director | $86,266 |
| Bart Friedman | Lead Independent Director | $105,754 |
| Jeremy M. Levin | Chair of the Board | $0 |
| Kevin Fitzgerald | Independent Director | $69,940 |
| Margaret Alexander | Director | $0 |
| Stelios Papadopoulos | Independent Director | $88,906 |
The full Ovid Therapeutics compensation record
free company briefThis page is one director within Ovid Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat